Holen Sie sich die Stockscreener-App
0.9999
0.26%
0.01
Schlusskurs vom Vortag:
$0.9899
Offen:
$1.01
24-Stunden-Volumen:
45,056
Relative Volume:
0.03
Marktkapitalisierung:
$382.83M
Einnahmen:
$106.34M
Nettoeinkommen (Verlust:
$-74.66M
KGV:
-1.0525
EPS:
-0.95
Netto-Cashflow:
$-46.12M
1W Leistung:
-6.37%
1M Leistung:
-16.60%
6M Leistung:
-25.38%
1J Leistung:
-12.94%
1-Tages-Spanne:
$0.9912
$1.0199
1-Wochen-Bereich:
$0.9611
$1.095
52-Wochen-Spanne:
$0.92
$1.72
Standard Biotools Inc Stock (LAB) Company Profile
Firmenname
Standard Biotools Inc
Sektor
Branche
Telefon
(650) 266-6000
Adresse
2 TOWER PLACE, SOUTH SAN FRANCISCO
Compare LAB vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
0.9955 | 379.10M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
110.20 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
358.70 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
90.19 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.54 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-13 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-02-27 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | Eingeleitet | TD Cowen | Buy |
| 2024-04-04 | Eingeleitet | Jefferies | Buy |
| 2023-07-12 | Eingeleitet | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Aktie (LAB) Neueste Nachrichten
Standard BioTools (NASDAQ:LAB) Cut to "Sell" at Wall Street Zen - MarketBeat
Retail Trends: Will Standard BioTools Inc stock hit new highs in YEARWeekly Market Report & Fast Momentum Entry Tips - baoquankhu1.vn
Does Standard BioTools Inc have declining or rising EPSJuly 2025 Chart Watch & Fast Momentum Entry Tips - baoquankhu1.vn
Aug PostEarnings: Should I invest in Standard BioTools Inc before earningsQuarterly Trade Summary & Expert Verified Movement Alerts - baoquankhu1.vn
LAB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
LAB Technical Analysis & ETF Price Forecast - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Eli Casdin boosts equity stake in STANDARD BIOTOOLS (LAB) with 52,991 RSUs - Stock Titan
Director at Standard BioTools (LAB) takes RSUs instead of cash pay - Stock Titan
Retail Trends: Is Standard BioTools Inc a strong growth stockJuly 2025 Analyst Calls & Weekly High Return Opportunities - baoquankhu1.vn
Standard BioTools (NASDAQ:LAB) Upgraded to Hold at Wall Street Zen - MarketBeat
Standard BioTools Inc. (LAB) Stock Analysis: Unveiling a 32% Upside Potential Amidst Challenging Metrics - DirectorsTalk Interviews
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Globus Medical (GMED), Standard BioTools (LAB) and Addus Homecare (ADUS) - The Globe and Mail
Standard BioTools (LAB) Q4 Profit Challenges Longstanding Unprofitable Narrative - Sahm
Standard BioTools Q4 2025 Results: Profit on $23.8M RevenueNews and Statistics - IndexBox
Standard BioTools Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Standard BioTools (LAB) Reports Strong Q4 Revenue Exceeding Expe - GuruFocus
Standard BioTools Inc (NASDAQ:LAB) Surges on Strong Q4 Earnings Beat - ChartMill
STANDARD BIOTOOLS (LAB) CEO has shares withheld to cover RSU tax bill - Stock Titan
Standard BioTools (LAB) SVP disposes shares for tax withholding - Stock Titan
Tax withholding trims Standard BioTools (LAB) CFO share stake - Stock Titan
Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results - Investing News Network
Standard Biotools earnings beat by $0.10, revenue topped estimates - Investing.com Canada
Standard BioTools Details SomaLogic Sale and Profitability Path - TipRanks
LAB Forecasts Revenue Between $80 Million and $85 Million for FY - GuruFocus
Standard BioTools: Q4 Earnings Snapshot - marketscreener.com
Standard BioTools (NASDAQ:LAB) Announces Earnings Results - MarketBeat
Standard BioTools Q4 Earnings Report: What Investors Need to Know - Benzinga
Preview: Standard BioTools's Earnings - Benzinga
Standard BioTools Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
Standard BioTools Inc. (LAB) Stock Analysis: Healthcare Innovator Shows 34.78% Potential Upside - DirectorsTalk Interviews
What hedge fund activity signals for Standard BioTools Inc. stock2025 Geopolitical Influence & Short-Term High Return Ideas - mfd.ru
MSN Money - MSN
Standard BioTools (LAB) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
How Standard BioTools Inc. stock performs during Fed tightening cyclesWeekly Trend Recap & Short-Term Trading Alerts - mfd.ru
Illumina Stock May Benefit From New Agreement to Acquire SomaLogic - MSN
Illumina completes acquisition of SomaLogic from Standard BioTools - BizWest
Standard BioTools Inc. (LAB) Stock Analysis: Unpacking a 39.64% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
LAB PE Ratio & Valuation, Is LAB Overvalued - Intellectia AI
Can Standard BioTools Inc. (FLB) stock survive global slowdownFed Meeting & Weekly Setup with ROI Potential - mfd.ru
Standard BioTools Inc.'s (NASDAQ:LAB) Popularity With Investors Under Threat As Stock Sinks 27% - simplywall.st
Can Standard BioTools Inc. stock outperform in a bear marketSwing Trade & Community Trade Idea Sharing Platform - mfd.ru
Will Standard BioTools Inc. stock recover after earningsJuly 2025 Retail & Reliable Trade Execution Plans - mfd.ru
Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - GlobeNewswire
Swing Trade: Will BayFirst Financial Corp benefit from geopolitical trends2025 Valuation Update & Weekly High Conviction Ideas - baoquankhu1.vn
Market Outlook: Can Standard BioTools Inc stock outperform in a bear market2025 Top Gainers & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
Standard BioTools Strengthens Balance Sheet with Major Divestiture - AD HOC NEWS
Standard BioTools Inc. (LAB) Stock Analysis: Exploring the 25% Potential Upside Amid Market Challenges - DirectorsTalk Interviews
Aug Patterns: Is Standard BioTools Inc impacted by rising ratesJuly 2025 Technicals & Weekly Market Pulse Alerts - baoquankhu1.vn
Market Pulse: Will Standard BioTools Inc stock recover after earnings2025 Momentum Check & Safe Entry Point Identification - baoquankhu1.vn
Illumina completes acquisition of SomaLogic - marketscreener.com
Finanzdaten der Standard Biotools Inc-Aktie (LAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.32%
1.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):